Our data demonstrated that ENKUR induced by CB suppresses HCC malignant activities via antagonizing β-catenin/c-Jun/MYH9/USP7/c-Myc-stimulated cell cycle and EMT pathways, which indicated the significance of ENKUR as a tumor suppressor in HCC. The gene discussed is MYH9; the disease is hepatocellular carcinoma.